KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organon (OGN) EBT Margin (2020 - 2025)

Organon (OGN) has 6 years of EBT Margin data on record, last reported at 9.82% in Q4 2025.

  • For Q4 2025, EBT Margin fell 1792.0% year-over-year to 9.82%; the TTM value through Dec 2025 reached 6.84%, down 577.0%, while the annual FY2025 figure was 6.84%, 577.0% down from the prior year.
  • EBT Margin reached 9.82% in Q4 2025 per OGN's latest filing, down from 15.17% in the prior quarter.
  • Across five years, EBT Margin topped out at 31.01% in Q1 2021 and bottomed at 98.45% in Q4 2022.
  • Average EBT Margin over 5 years is 9.16%, with a median of 14.67% recorded in 2021.
  • Peak YoY movement for EBT Margin: crashed -11317bps in 2022, then surged 10496bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 14.72% in 2021, then crashed by -769bps to 98.45% in 2022, then surged by 107bps to 6.51% in 2023, then grew by 25bps to 8.1% in 2024, then plummeted by -221bps to 9.82% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 9.82% in Q4 2025, 15.17% in Q3 2025, and 14.37% in Q2 2025.